Search

Now showing items 1-4 of 4

Load kick-back effects due to activation of demand response in view of distribution grid operation

Type: Conference Paper

Author : Han, Xue; Sossan, Fabrizio; Bindner, Henrik W.; You, Shi; Hansen, Henrik; Cajar, Peder D.

Publisher: IEEE

Year: 2014

Vapor-liquid equilibria by UNIFAC group contribution. 5. Revision and extension

Type: Journal Paper

Author : Hansen, Henrik K.; Rasmussen, Peter; Fredenslund, Aage; Schiller, Martin; Gmehling, Juergen

Year: 1991

Request PDF

InÂ vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one (RVX-208)

Type: Journal Paper

Author : Khmelnitsky, Yuri L.; Mozhaev, Vadim V.; Cotterill, Ian C.; Michels, Peter C.; Boudjabi, Sihem; Khlebnikov, Vladimir; Madhava Reddy, M.; Wagner, Gregory S.; Hansen, Henrik C.

Year: 2013

Request PDF

LNA-mediated microRNA silencing in non-human primates

Type: Journal Paper

Author : Elmén, Joacim; Lindow, Morten; Schütz, Sylvia; Lawrence, Matthew; Petri, Andreas; Obad, Susanna; Lindholm, Marie; Hedtjärn, Maj; Hansen, Henrik Frydenlund; Berger, Urs

Publisher: Nature Publishing Group

Year: 2008

Request PDF

Search

Load kick-back effects due to activation of demand response in view of distribution grid operation

Vapor-liquid equilibria by UNIFAC group contribution. 5. Revision and extension

InÂ vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one (RVX-208)

LNA-mediated microRNA silencing in non-human primates

Author

Publisher

Year

Keywords

Type

Language (ISO)

Content Type

Publication Title

Search

Filters

Load kick-back effects due to activation of demand response in view of distribution grid operation

Vapor-liquid equilibria by UNIFAC group contribution. 5. Revision and extension

InÂ vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one (RVX-208)

LNA-mediated microRNA silencing in non-human primates